Effect of Intragastric Balloons on Liver Enzymes: A Systematic Review and Meta-Analysis
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Background Intragastric balloons (IGBs) are safe and effective in inducing weight loss in obese patients. The objective of this study was to review and analyze the available data of the effect of IGB on markers of nonalcoholic fatty liver disease (NAFLD) and liver enzymes. Methods Searches were performed of MEDLINE and Embase databases from inception through January 2016. Study inclusion criteria were the following: ≥5 overweight or obese adult patients undergoing intragastric balloon placement, with liver tests [alanine aminotransferase (ALT) or gamma-glutamyl transpeptidase (GGT)] or markers of NAFLD (e.g., imaging, biopsy) reported before balloon insertion and after balloon removal at 6 months. Results Nine observational studies and one randomized trial were identified. ALT decreased by -10.02 U/l (95 % CI, -13.2, -6.8), GGT decreased by -9.82 U/l (95 % CI, -12.9, -6.8), and BMI decreased by -4.98 kg/m(2) (-5.6, -4.4) with IGB therapy. Hepatic steatosis improved from baseline after 6 months of balloon therapy by magnetic resonance imaging (fat fraction, 16.7 ± 10.9-7.6 ± 9.8, p = 0.003), ultrasound (severe liver steatosis, 52-4 %, p Conclusion The use of intragastric balloon decreases liver enzymes and is potentially an effective short-term treatment for NAFLD as part of a multidisciplinary approach. Larger, more rigorous trials are needed to confirm the effect of IGBs on NAFLD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a reduction in NAS scores from 4 ± 2.25 to 2 ± 0.75 (p = 0.03) within six months [72].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [72]
In the citing paper
“a cohort study employing magnetic resonance elastography and liver biopsies found an 87% patient cohort experienced a median NAS reduction of three points, with 73% achieving reductions of at least two points [73].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [72]
In the citing paper
“Complementary evidence from a systematic review highlighted a significant histological improvement, demonstrating a reduction in NAS scores from 4 ± 2.25 to 2 ± 0.75 (p = 0.03) within six months [72].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [72]
In the citing paper
“studies utilizing ultrasound and MRI observed hepatic fat fraction reductions from 16.7 ± 10.9 to 7.6 ± 9.8 (p = 0.003) [72].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [72]
Citations
Cites
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
The global obesity pandemic: shaped by global drivers and local environments
Swinburn, B. A., Sacks, G., Hall, K. D., McPherson, K., Finegood, D. T., Moodie, M. L., & Gortmaker, S. L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60813-1 · Cited by 4,888
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Chang, S.-H., Stoll, C. R. T., Song, J., Varela, J. E., Eagon, C. J., & Colditz, G. A. (2014) · JAMA Surgery · doi:10.1001/jamasurg.2013.3654 · Cited by 1,688
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,610
Obesity in Adulthood and Its Consequences for Life Expectancy: A Life-Table Analysis
Peeters, A., Barendregt, J. J., Willekens, F., Mackenbach, J. P., Mamun, A. A., Bonneux, L., & and for NEDCOM, T. N. E. A. D. C. O. M. R. G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00008 · Cited by 1,479
Updated definitions of healthy ranges for serum alanine aminotransferase levels
Prati, D., Taioli, E., Zanella, A., Torre, E. D., Butelli, S., Del Vecchio, E., Vianello, L., Zanuso, F., Mozzi, F., Milani, S., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00006 · Cited by 1,445
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
Promrat, K., Kleiner, D. E., Niemeier, H. M., Jackvony, E., Kearns, M., Wands, J. R., Fava, J. L., & Wing, R. R. (2010) · Hepatology · doi:10.1002/hep.23276 · Cited by 1,330
Brunt, E. M., Kleiner, D. E., Wilson, L. A., Belt, P., & Neuschwander-Tetri, B. A. (2011) · Hepatology · doi:10.1002/hep.24127 · Cited by 1,251
Cusi, K. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.003 · Cited by 911
Endpoints and clinical trial design for nonalcoholic steatohepatitis
Sanyal, A. J., Brunt, E. M., Kleiner, D. E., Kowdley, K. V., Chalasani, N., Lavine, J. E., Ratziu, V., & McCullough, A. (2011) · Hepatology · doi:10.1002/hep.24376 · Cited by 750
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.128 · Cited by 585
Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis
Keating, S. E., Hackett, D. A., George, J., & Johnson, N. A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.023 · Cited by 537
Lee, D. S., Evans, J. C., Robins, S. J., Wilson, P. W., Albano, I., Fox, C. S., Wang, T. J., Benjamin, E. J., D’Agostino, R. B., & Vasan, R. S. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000251993.20372.40 · Cited by 530
Thoma, C., Day, C. P., & Trenell, M. I. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.06.010 · Cited by 523
Mathurin, P., Hollebecque, A., Arnalsteen, L., Buob, D., Leteurtre, E., Caiazzo, R., Pigeyre, M., Verkindt, H., Dharancy, S., Louvet, A., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.052 · Cited by 483
Safety and Effectiveness of the Intragastric Balloon for Obesity. A Meta-Analysis
Imaz, I., Martínez-Cervell, C., García-Álvarez, E. E., Sendra-Gutiérrez, J. M., & González-Enríquez, J. (2008) · Obesity Surgery · doi:10.1007/s11695-007-9331-8 · Cited by 419
Daniel, S. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00507-9 · Cited by 354
Martin, M., Beekley, A., Kjorstad, R., & Sebesta, J. (2010) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2009.07.003 · Cited by 338
Ponce, J., Woodman, G., Swain, J., Wilson, E., English, W., Ikramuddin, S., Bour, E., Edmundowicz, S., Snyder, B., Soto, F., et al. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.12.006 · Cited by 279
Yamada, J., Tomiyama, H., Yambe, M., Koji, Y., Motobe, K., Shiina, K., Yamamoto, Y., & Yamashina, A. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.11.036 · Cited by 241
Dixon, J., Bhathal, P., & O'Brien, P. (2006) · Obesity Surgery · doi:10.1381/096089206778663805 · Cited by 212
Evidence-based Review of the Bioenterics Intragastric Balloon for Weight Loss
Dumonceau, J.-M. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9593-9 · Cited by 202
Marchesini, G., Avagnina, S., Barantani, E. G., Ciccarone, A. M., Corica, F., Dall’Aglio, E., Grave, R. D., Morpurgo, P. S., Tomasi, F., & Vitacolonna, E. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03347199 · Cited by 170
Thompson, C. C., Chand, B., Chen, Y. K., DeMarco, D. C., Miller, L., Schweitzer, M., Rothstein, R. I., Lautz, D. B., Slattery, J., Ryan, M. B., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.04.002 · Cited by 165
Self-citationA pathway to endoscopic bariatric therapies
(2011) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2011.09.008 · Cited by 158
Hepatic steatosis and insulin resistance: Does etiology make a difference?
Lonardo, A., Lombardini, S., Scaglioni, F., Carulli, L., Ricchi, M., Ganazzi, D., Adinolfi, L. E., Ruggiero, G., Carulli, N., & Loria, P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.06.018 · Cited by 153
U. L. Mathiesen, L. E. F. (1999) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365529950172880 · Cited by 149
A pathway to endoscopic bariatric therapies
Ginsberg, G. G., Chand, B., Coté, G. A., Dallal, R. M., Edmundowicz, S. A., Nguyen, N. T., Pryor, A. D., & Thompson, C. C. (2011) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2011.08.053 · Cited by 134
Self-citationLee, Y.-M., Low, H. C., Lim, L. G., Dan, Y. Y., Aung, M. O., Cheng, C. L., Wee, A., Lim, S. G., & Ho, K. Y. (2012) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2012.05.023 · Cited by 132
Thamer, C., Tschritter, O., Haap, M., Shirkavand, F., Machann, J., Fritsche, A., Schick, F., Häring, H., & Stumvoll, M. (2005) · Hormone and Metabolic Research · doi:10.1055/s-2005-861411 · Cited by 119
Zerrweck, C., Maunoury, V., Caiazzo, R. J., Branche, J., Dezfoulian, G., Bulois, P., Verkindt, H., Pigeyre, M., Arnalsteen, L., & Pattou, F. N. (2012) · Obesity Surgery · doi:10.1007/s11695-011-0571-2 · Cited by 104
Forlano, R., Ippolito, A. M., Iacobellis, A., Merla, A., Valvano, M. R., Niro, G., Annese, V., & Andriulli, A. (2010) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2009.06.036 · Cited by 104
Ryou, M. K., Cantillon‐Murphy, P., Azagury, D. E., Shaikh, S. N., Ha, G., Greenwalt, I. T., Ryan, M. B., Lang, J. H., & Thompson, C. C. (2010) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2010.10.024 · Cited by 91
Self-citationRevisional bariatric surgery for failed restrictive procedures
Coakley, B. A., Deveney, C. W., Spight, D. H., Thompson, S. K., Le, D., Jobe, B. A., Wolfe, B. M., McConnell, D. B., & O’Rourke, R. W. (2007) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2007.10.004 · Cited by 86
Weight reduction for non-alcoholic fatty liver disease
Peng, L., Wang, J., & Li, F. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003619.pub3 · Cited by 61
Ricci, G., Bersani, G., Rossi, A., Pigò, F., Fabritiis, G. D., & Alvisi, V. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9487-x · Cited by 57
Relationship of Liver Enzymes to Insulin Sensitivity and Intra-Abdominal Fat
Wallace, T. M., Utzschneider, K. M., Tong, J., Carr, D. B., Zraika, S., Bankson, D. D., Knopp, R. H., & Kahn, S. E. (2007) · Diabetes Care · doi:10.2337/dc06-1758 · Cited by 57
Evolving aspects of liver transplantation for nonalcoholic steatohepatitis
Charlton, M. (2013) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283615d30 · Cited by 53
Current Status of Endoluminal Bariatric Procedures for Primary and Revision Indications
Ryou, M. K., Ryan, M. B., & Thompson, C. C. (2011) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2011.02.004 · Cited by 50
Self-citationIntragastric Balloon Treatment for Obesity: Results of a Large Single Center Prospective Study
Štimac, D., Majanović, S. K., Wensveen, T. T., Kezele, B., Licul, V., & Orlić, Ž. C. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0310-0 · Cited by 50
Folini, L., Veronelli, A., Benetti, A., Pozzato, C., Cappelletti, M., MASCI, E., Micheletto, G., & Pontiroli, A. E. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0516-4 · Cited by 50
Tai, C., Lin, H., Yen, Y., Huang, C., Hsu, W., Huang, Y.-W., Chang, C., Wang, H., & Mo, L. (2013) · Obesity Surgery · doi:10.1007/s11695-013-1027-7 · Cited by 47
(2015) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2015.00019 · Cited by 46
Self-citationde Jonge, C., Rensen, S. S., Koek, G. H., Joosten, M. F., Buurman, W. A., Bouvy, N. D., & Greve, J. W. M. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.07.029 · Cited by 43
Takihata, M., Nakamura, A., Aoki, K., Kimura, M., Sekino, Y., Inamori, M., Maeda, S., Gotoh, E., Nakajima, A., & Terauchi, Y. (2013) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2013.07.002 · Cited by 29
Chen, Z., Han, C., Pan, L., Zhang, H., Ma, Z., Huang, Z., Chen, S., Zhuang, X., Li, Z., Li, X., et al. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3214-3 · Cited by 28
Metabolic parameters after BioEnterics Intragastric Balloon placement in obese patients
Donadio, F., Sburlati, L. F., Masserini, B., Lunati, E., Lattuada, E., Zappa, M. A., Mozzi, E., Beck‐Peccoz, P., & Orsi, E. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345708 · Cited by 25
Sekino, Y., Imajo, K., Sakai, E., Uchiyama, T., Iida, H., Endo, H., Hosono, K., Sakamoto, Y., Fujita, K., Yoneda, M., et al. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.5672 · Cited by 24
Obesity Treatment Using a Bioenterics Intragastric Balloon (BIB)—Preliminary Croatian Results
Nikolic, M., Mirošević, G., Ljubičić, N., Boban, M., Supanc, V., Pezo-Nikolić, B., Zjačić-Rotkvić, V., Bekavac‐Beslin, M., & Gaćina, P. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0101-7 · Cited by 22
Obesity and bariatrics for the endoscopist: new techniques
Dayyeh, B. K. A., & Thompson, C. C. (2011) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x11398737 · Cited by 18
Self-citation
Cited by
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Polyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.014 · Cited by 1,211
“Another meta-analysis, specific for intragastric balloons, showed decrease in LFTs, steatosis and NAS six months post-surgery [201].”
BackgroundYanai, H., Adachi, H., Hakoshima, M., Iida, S., & Katsuyama, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015473 · Cited by 194
“To review and analyze the available data of the effect of intragastric balloons on markers of MASLD and liver enzymes, a meta-analysis was performed [78].”
MethodJirapinyo, P., McCarty, T. R., Dolan, R. D., Shah, R., & Thompson, C. C. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.03.017 · Cited by 86
Self-citationJagtap, N., Kalapala, R., Katakwar, A., Sharma, M., Aslam, M., Gupta, R., Rao, P. N., Goud, R., Tandan, M., Kanakagiri, H., et al. (2021) · Indian Journal of Gastroenterology · doi:10.1007/s12664-021-01202-7 · Cited by 43
“Though more rigorous trials are needed to confirm the effects of various endoscopic interventions, they can be considered for weight loss in NAFLD if lifestyle interventions fail [37].”
BackgroundXu, L., Jiang, C. Q., Lam, T. H., Zhang, W. S., Zhu, F., Jin, Y. L., Thomas, G. N., Cheng, K. K., & Schooling, C. M. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw396 · Cited by 34
“adiposity (23) or lipids (24)) were also associated with ALT, further MR studies using functionally related loci are helpful in addressing the potential issue of reverse causation (i.”
Background
Metadata
- Authors
- Popov, V. B., Thompson, C. C., Kumar, N., Ciarleglio, M. M., Deng, Y., & Laine, L.
- Affiliations
- VA NY Harbor Healthcare System (US)
- Brigham and Women's Hospital (US)
- Yale University (US)
- Corresponding author
- Popov, Violeta B.
- ORCID
- Venue
- Digestive Diseases and Sciences
- Published
- 2016-05-20
- Volume
- 61
- Issue
- 9
- Pages
- 2477-2487
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- OpenAlex
- W2406248787
- Cited by
- 43
- References
- 54
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 7 · 2023: 5 · 2022: 3 · 2021: 12 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 2 · 2016: 2
- FWCI
- 0.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Digestive Diseases and Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK34989)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Keywords
- intragastric balloon, non-alcoholic fatty liver disease, liver enzymes, alanine aminotransferase, gamma-glutamyl transferase, hepatic steatosis, obesity, weight loss, NAFLD activity score
- MeSH terms
- Alanine Transaminase, gamma-Glutamyltransferase, Humans, Liver, Obesity, Ultrasonography, Weight Loss, Gastric Balloon, Treatment Outcome, Bariatric Surgery, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.